
The GLP-1 boom has a dark side, although serious complications are rare – The Washington Post
- The GLP-1 boom has a dark side, although serious complications are rare The Washington Post
- Take Ozempic or Wegovy? The FDA says there’s a new warning you shouldn’t ignore Fast business
- FDA orders new eye risks listed on a dozen GLP-1s, including Novo’s Ozempic and Lilly’s Zepbound Fierce pharmaceutical
- Hopkins expert offers advice after FDA warning about GLP-1 and blindness The Baltimore Banner
- FDA issues new safety warning on GLP-1 drugs Page Med today
Gn bussni